04:46 PM EDT, 07/21/2025 (MT Newswires) -- Medpace ( MEDP ) reported Q2 earnings late Monday of $3.10 per diluted share, up from $2.75 a year earlier.

Analysts polled by FactSet expected $2.98.

Revenue for the quarter ended June 30 was $603.3 million, up from $528.1 million a year earlier.

Analysts surveyed by FactSet expected $538.8 million.

For full-year 2025, the company raised its EPS guidance to a range of $13.76 to $14.53 from the previous range of $12.26 to $13.04. Revenue projection for the year was raised to $2.42 billion to $2.52 billion from the previous range of $2.14 billion to $2.24 billion.

Analysts surveyed by FactSet expect EPS of $12.75 on revenue of $2.19 billion.

Shares of the company jumped nearly 45% in recent after-hours activity.

Price: 446.75, Change: +137.87, Percent Change: +44.64